mrx-4dp0004

Cell therapyexperimental

Clinical trial activity

2 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started May 31, 2019 (NCT03851250)

Timeline

2010s

  1. Jan 1, 2019

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • microbiotaTissue restoration

    microbiota tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04363372Phase 2May 31, 20204DPharma PLC, University of Leeds
NCT03851250Phase 1/Phase 2 (Phase 2)May 31, 20194DPharma PLC, University of Leicester
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
4DPharma PLCFor profit2212019
University of LeedsAcademic/Hospital1012020
University of LeicesterAcademic/Hospital1012019
3 organizations
Page 1 / 1